Resources Contact Us Home
Method for therapeutically treating abnormal cells expressing a major histocompatibility complex class II antigen using cytolytic inducer T4 cells

Image Number 2 for United States Patent #4861589.

The present invention provides a lymphocyte-mediated immunotherapy for the treatment of human or animal subjects afflicted with abnormal or tumor cells which express a MHC Class II antigen on their surface. The method utilizes inducer T-cell clones or lines having a demonstrable specificity for an identifiable antigen. These T-cells are activated in-vivo to express cytolytic and therapeutic activity against the abnormal or tumor cells in the subject.

  Recently Added Patents
Tap initialization of equalizer based on estimated channel impulse response
Method and apparatus for providing very high throughput operation and capability signaling for wireless communications
High-frequency-link power-conversion system having direct double-frequency ripple current control and method of use
Keyswitch controller
Methods to fabricate a photoactive substrate suitable for microfabrication
Image stabilization apparatus and image pickup apparatus
Methods and systems for providing a business repository
  Randomly Featured Patents
Method and apparatus for obtaining status of public key certificate updates
Roof structure of a motor vehicle
Electrical stressing means
Activation plate for electroless and immersion plating of integrated circuits
Structural support bracket
Woven fabric containing partially fibrillated textile yarn
Divers console with knife and sheath
Support for an ear protector
Parallel hybrid drivetrain
Mounting device for vehicle shock absorber